Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03453541 · ClinicalTrials.gov registry record · Phase 4
Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy
A Phase 4 study, sponsored by Albany Medical College.
- Terminated
- Registry status
- Phase 4
- Development phase
- 214
- Enrollment target
NCT03453541: Clinical Trial Phase 4 study, sponsored by Albany Medical College.
NCT03453541 is a Phase 4 study that was terminated before completion, run by Albany Medical College. The registered enrollment target is 214 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03453541, a Phase 4 study, was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 214 participants
- Enrollment target
Study Summary
This prospective, randomized, double blinded study is designed to compare the bleeding rates of ketorolac vs. placebo when used for post tonsillectomy pain control in pediatric patients ages 2-18.
Primary Outcome
Rebleeding rate requiring operative intervention measured by recording either yes or no the patient did or did not returned to the OR for bleeding related to recent tonsillectomy. Requiring operative intervention would be a worse outcome than not requiring operative intervention.
Interventions
- DRUG Ketorolac Tromethamine
- DRUG 0.9% Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2022-11-01 |
| Phase | Phase 4 |
Why NCT03453541 stopped before completion
NCT03453541 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketorolac Tromethamine is the first listed.
NCT03453541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03453541 about?
NCT03453541 is a clinical study titled "Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy". This prospective, randomized, double blinded study is designed to compare the bleeding rates of ketorolac vs. placebo when used for post tonsillectomy pain control in pediatric patients ages 2-18.
What is the current status of trial NCT03453541?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 214 participants. The study started on 2017-11-21. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03453541?
The interventions under investigation include: Ketorolac Tromethamine (DRUG), 0.9% Normal Saline (DRUG).
Who is sponsoring clinical trial NCT03453541?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03453541's enrollment target sits among peer trials
214 394th of 2000 higher than 1,605 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI